首页> 美国卫生研究院文献>Cancer Management and Research >The novel sugar transporter SLC50A1 as a potential serum-based diagnostic and prognostic biomarker for breast cancer

【2h】

The novel sugar transporter SLC50A1 as a potential serum-based diagnostic and prognostic biomarker for breast cancer

机译：新型糖转运蛋白SLC50A1可作为潜在的基于血清的乳腺癌诊断和预后生物标志物

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThe novel sugar transporter and membrane protein SLC50A1 has been identified as a potential candidate biomarker for breast cancer; however, its potential as a serum biomarker for breast cancer detection and prognosis is unclear. The aim of this study was to investigate the serum expression profile of SLC50A1 and to determine its diagnostic and prognostic significance in breast cancer.

机译：背景：新型糖转运蛋白和膜蛋白SLC50A1已被确定为乳腺癌的潜在候选生物标志物。然而，其作为乳腺癌检测和预后的血清生物标志物的潜力尚不清楚。这项研究的目的是调查SLC50A1的血清表达谱，并确定其在乳腺癌中的诊断和预后意义。

著录项

期刊名称 Cancer Management and Research
作者
Yu Wang; Yao Shu; Congyang Gu; Yu Fan;
展开▼
作者单位

展开▼
年(卷),期 2019(11),-1
年度 2019
页码 865–876
总页数 12
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
breast cancer SLC50A1 biomarker serum prognosis;

机译：乳腺癌;SLC50A1;生物标志物;血清;预后;

相似文献

外文文献
中文文献
专利

1. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers [J] . Liu Yiduo, Teng Linxin, Fu Shiyi, BMC Cancer . 2021,第1期

机译：高度阴性乳腺癌的高度异质相关基因：潜在的诊断和预后生物标志物
2. Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer [J] . TangX. Cancer letters . 2013,第1期

机译：肿瘤相关巨噬细胞作为乳腺癌的潜在诊断和预后生物标志物
3. Circulating HER-2 mRNA in the peripheral blood as a potential diagnostic and prognostic biomarker in females with breast cancer [J] . Wu Yanlin, Meng Qiping, Yang Zhixue, Oncology letters . 2018,第3aPta2期

机译：将HER-2 mRNA循环在外周血中作为乳腺癌患者的潜在诊断和预后生物标志物
4. Serum Biomarker Concentrations in Benign Breast Conditions and Ductal Carcinoma In Situ: Designing a Diagnostic Biomarker Panel That Can Distinguish Between Benign Conditions and Invasive Breast Cancer [C] . David E. Reese, Meredith C. Henderson, Susan Yeh, Molecular Medicine TRI-CON. . 2014

机译：血清生物标志物浓度在良性乳腺条件和导管癌原位：设计诊断生物标志物面板，可以区分良性条件和侵袭性乳腺癌
5. Development of novel biomarkers in cancer: Detection of circulating miR-141 as a potential prognostic marker for prostate cancer. [D] . Gonzales, Jason Cadaoas. 2010

机译：癌症中新型生物标志物的开发：检测循环miR-141作为前列腺癌的潜在预后标志物。
6. AGR3 in Breast Cancer: Prognostic Impact and Suitable Serum-Based Biomarker for Early Cancer Detection [O] . Stefan Garczyk, Saskia von Stillfried, Wiebke Antonopoulos, -1

机译：乳腺癌中的AGR3：对早期癌症的预后影响和基于血清的生物标志物
7. The novel sugar transporter SLC50A1 as a potential serum-based diagnostic and prognostic biomarker for breast cancer [O] . Yu Wang, Yao Shu, Congyang Gu, 2019

机译：新型糖转运蛋白SLC50A1作为乳腺癌的潜在血清诊断和预后生物标志物
8. Assessing EphA2 and Ephrin-A as Novel Diagnostic and Prognostic Biomarkers of Prostate Cancer. [R] . Nguyen, C. 2017

机译：评估Epha2和Ephrin-a作为前列腺癌的新型诊断和预后生物标志物。

The novel sugar transporter SLC50A1 as a potential serum-based diagnostic and prognostic biomarker for breast cancer

摘要

著录项

相似文献

相关主题

期刊订阅